Protocol Ledger

NCT06036927 · Phase II · COMPLETED

A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps

Interventional Phase II clinical trial protocol NCT06036927 sponsored by Chia Tai Tianqing Pharmaceutical Group Co in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-12-08 Enrollment: 80 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06036927
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)80 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06036927
Protocol FieldVerified Registry Value
NCT IdentifierNCT06036927
Consolidated Lead SponsorChia Tai Tianqing Pharmaceutical Group Co
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment80 participants (ACTUAL)
Registered Start Date2023-12-08
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06036927
Hospital Research SiteLocationSite Profile
ZhuJiang Hospital of Southern Medical UniversityGuangzhou, ChinaOpen Hospital Dossier ->
The Affiliated Hospital of Xuzhou Medical UniversityXuzhou, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI